ECOSPOR III - SER-109 Versus Placebo in the Treatment of Adults With Recurrent Clostridium Difficile Infection
Clinical trial NCT03183128 · COMPLETED
Trial details
- NCT number
- NCT03183128
- Sponsor
- Seres Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-10
- Primary completion
- 2020-07-03
- Enrollment
- 182
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.